Lyell Immunopharma (LYEL) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to -$19.9 million.
- Lyell Immunopharma's Other Gross PP&E Adjustments rose 4568.76% to -$19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.9 million, marking a year-over-year increase of 4568.76%. This contributed to the annual value of $84.1 million for FY2024, which is 1865.68% down from last year.
- Latest data reveals that Lyell Immunopharma reported Other Gross PP&E Adjustments of -$19.9 million as of Q3 2025, which was up 4568.76% from -$21.0 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments ranged from a high of $104.7 million in Q4 2022 and a low of -$48.4 million during Q2 2021
- In the last 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments had a median value of -$38.2 million in 2024 and averaged -$8.6 million.
- In the last 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments soared by 18433.45% in 2021 and then crashed by 1865.68% in 2024.
- Quarter analysis of 5 years shows Lyell Immunopharma's Other Gross PP&E Adjustments stood at $85.2 million in 2021, then rose by 22.88% to $104.7 million in 2022, then fell by 1.24% to $103.4 million in 2023, then dropped by 18.66% to $84.1 million in 2024, then plummeted by 123.68% to -$19.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$19.9 million for Q3 2025, versus -$21.0 million for Q2 2025 and -$23.6 million for Q1 2025.